Application
MHY1485 has been used:
- to study the effect of mammalian target of rapamycin mTOR signalling on in vitro O-GlcNAcylation
- to inhibit autophagy
- as a mTOR agonist to demonstrate that the O-linked N-acetylglucosamine transferase- RNA helicase p68 (OGT-DDX5) axis regulates colorectal cancer cell proliferation and metastasis
Biochem/physiol Actions
MHY1485 binds to the mammalian target of rapamycin (mTOR) and stimulates its action. MHY1485 has the ability to penetrate the cell. It prevents the ultraviolet-induced oxidative stress in keratinocytes and fibroblasts.
MHY1485 is mTOR activator that potently inhibits autophagy by suppression of fusion between autophagosomes and lysosomes.
Features and Benefits
This compound is a featured product for Apoptosis research. Click here to discover more featured Apoptosis products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.
This compound is featured on the PKB/Akt page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
- UPC:
- 41114406
- Condition:
- New
- HazmatClass:
- No
- MPN:
- SML0810-25MG
- CAS:
- 326914-06-1
akash.verma@cenmed.com
(732) 447-1115





